Biorithm
Femom
2021
Research, Concept, Development, Packaging + Production
Biorithm Femom fetal monitor
Gathering essential maternal and fetal physiological data to monitor the health of mother and baby for at risk pregnancy.
Femom is designed to capture essential maternal and fetal bio-signals to determine the health of the mother and baby in a clinical and home setting. The Femom fetal monitor leverages on Non-Invasive Fetal Electrocardiogram (NIFECG) and Electrohysterography (EHG) monitoring. Femom helps clinicians to identify early signs of risks before they become emergencies, working to ensure a safer and smoother journey for mother and baby.
Femom aims to provide greater convenience for expecting mothers and better data resolution on babies well-being given the frequency of monitoring and in-depth data analysis. The wearable device sends data to the Femom companion smartphone application, recording a session in confidence via the app, thus keeping the mother calm without unnecessary duress. The monitoring session data is then sent to the assigned obstetrician for clinical review.
Advancing Fetal monitoring technology.
Fetal monitoring via CTG has remained largely unchanged since its invention in the 1960s and currently requires in-person visits to the Hospital.
Fetal heart rate monitoring is currently performed in healthcare provider environments (i.e. Hospitals) via cardiotocography (CTG) technology. Fetal monitoring via CTG has remained largely unchanged since its invention in the 1960s. The key challenge was to provide mothers and obstetricians with a simple home monitoring wearable device that would provide peace of mind (for mothers), repeatable and reliable medical data collected by the mothers themselves, and timely support for at-risk pregnancy (results interpreted by obstetricians/midwives remotely).
High risk conditions affect roughly 20% of pregnancies worldwide, approximately 33 million women with these numbers growing yearly. Pregnancy risks are increased by chronic diseases such as hypertension, diabetes and the fact that more women are choosing to give birth later in life. High risk pregnancies present an increased chance of preterm and/or stillbirth, with the journey marked by endless visits to hospitals, undergoing multiple repeated tests and scans. In many cases, this requires the mother to visit the hospital multiple times per week, a major disruption to everyday life. In some cases, such as living rurally, long distance travel is required to receive this care, costing time and money. This can sometimes lead to an anxious and tiring maternity experience for many mothers.
The device needed to capture accurate data about maternal and fetal heart rates, and uterine contractions, for the purpose of enabling faster responses to any concerns or risks before they become emergencies.
A safe and convenient way to assess well-being.
A prescribed obstetric wearable monitoring device that acquires electrophysiological signals from the mother and baby.
Femom provides mothers with a safe and convenient way to assess well-being from the comfort of home and equips clinicians with the ability to detect early warning signs of maternal/fetal distress before they become emergencies. Femom is a prescribed obstetrics solution consisting of a wearable monitoring device containing an electrode sensor array that senses electrophysiological signals from the mother and baby. Femom provides monitoring of the maternal heart rate, fetal heart rate, and uterine activity in the antepartum periods.
The Femom patient mobile app instantly captures results, monitoring history, and provides tools to communicate with clinicians through the clinician web platform.
A connected care solution for expecting mothers and clinicians.
Femom empowers mothers and clinicians with an easy to use tool to ensure proactive care and greater peace of mind.
Femom places control into the hands of the mother by enabling fetal and maternal monitoring to take place from the comfort of the home. Femom has been designed and developed by putting the mother at the center of care to ensure greater usability and overall monitoring experience.
Biorithm’s Femom device is an innovative maternal-fetal connected care solution for expecting mothers and maternity healthcare providers. Femom’s home-monitoring approach provides mothers with a safe and convenient way to access maternity care and equip clinicians with the ability to detect early warning signs of maternal/fetal distress before they become emergencies. The solution works to minimise pregnancy risks to the mother and baby and minimises disruptions to daily life by removing the need for regular travel to the traditional point of care (i.e. Hospital) to complete tests and scans.
Femom has the potential to enhance the journey of up to 33 million high-risk expecting mothers each year. Femom’s holistic approach to home-monitoring wearables leads to a new maternity care standard by empowering clinicians with higher data resolution to deliver timely intervention while offering mother’s a smooth journey into motherhood.
